Should I buy or sell Fisher & Paykel Healthcare stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FSPKF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares. View FSPKF analyst ratings or view top-rated stocks .

How have FSPKF shares performed in 2024?

Fisher & Paykel Healthcare's stock was trading at $14.11 at the start of the year. Since then, FSPKF shares have increased by 10.8% and is now trading at $15.64. View the best growth stocks for 2024 here .

Are investors shorting Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,786,000 shares, an increase of 10.3% from the March 15th total of 1,619,600 shares. Based on an average daily trading volume, of 1,300 shares, the days-to-cover ratio is currently 1,373.8 days. View Fisher & Paykel Healthcare's Short Interest .

Is Fisher & Paykel Healthcare a good dividend stock?

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) pays an annual dividend of $0.07 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Fisher & Paykel Healthcare?

Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:FSPKF

Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free FSPKF Stock Alerts

$15.64

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $15.64
▼
$15.64
50-Day Range: $14.57
▼
$15.64
52-Week Range: $12.00
▼
$16.69

Volume: N/A
Average Volume: 2,875 shs
Market Capitalization: N/A

P/E Ratio: 92.20
Dividend Yield: 0.42%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Get Fisher & Paykel Healthcare alerts:

Fisher & Paykel Healthcare MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.50
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.05 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Fisher & Paykel Healthcare.

0.0

Short Interest

Percentage of Shares Shorted
Short Interest Ratio / Days to Cover
Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 1373.8, which indicates bearish sentiment.
Change versus previous month
Short interest in Fisher & Paykel Healthcare has recently increased by 10.27%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
Fisher & Paykel Healthcare pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fisher & Paykel Healthcare does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fisher & Paykel Healthcare is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FSPKF.

0.8

News and Social Media Coverage

News Sentiment
Fisher & Paykel Healthcare has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Fisher & Paykel Healthcare this week, compared to 0 articles on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fisher & Paykel Healthcare insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 31.42% of the stock of Fisher & Paykel Healthcare is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Fisher & Paykel Healthcare is 92.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.21.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fisher & Paykel Healthcare is 92.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 248.92.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Fisher & Paykel Healthcare Stock (OTCMKTS:FSPKF)

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

FSPKF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FSPKF Stock News Headlines

April 11, 2024 | americanbankingnews.com

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Trading 2.4% Higher

March 27, 2024 | msn.com

Breathing devices recalled by Fisher and Paykel Healthcare

April 15, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 27, 2024 | markets.businessinsider.com

Jarden Sticks to Its Sell Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

November 28, 2023 | msn.com

Fisher & Paykel ups pre-Christmas dividend

November 28, 2023 | marketwatch.com

Fisher & Paykel Lifts 1H Profit 12% Amid Easing Freight Costs

October 14, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) institutional investors lost 5.6% last week but have benefitted from longer-term gains

October 8, 2023 | markets.businessinsider.com

Jarden Remains a Hold on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

April 15, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

September 26, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Polynovo Limited (OtherCALZF)

September 3, 2023 | msn.com

Fisher & Paykel’s 30-year master plan requires ‘discipline’

August 28, 2023 | msn.com

Fisher and Paykel Healthcare forecasting return to revenue growth

August 14, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) Is Reinvesting At Lower Rates Of Return

May 31, 2023 | markets.businessinsider.com

Jarden downgrades Fisher & Paykel Healthcare Corporation Limited (FSPKF) to a Hold

May 25, 2023 | markets.businessinsider.com

Citi Remains a Hold on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

May 24, 2023 | markets.businessinsider.com

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Gets a Buy from Jarden

May 12, 2023 | marketwatch.com

Obstructive Sleep Apnea Devices Market Size 2023 Analysis by Global Key Players -ResMed, Philips, Fisher & Paykel Healthcare

May 9, 2023 | marketwatch.com

Sleep Apnea Monitoring Instruments Market 2023 Is Growing Worldwide – ResMed, Philips Healthcare Fisher & Paykel Healthcare

May 9, 2023 | marketwatch.com

Obstructive Sleep Apnea Devices Market Size & Share Analysis – Latest Insight Report | ResMed, Philips, Fisher & Paykel Healthcare

May 5, 2023 | marketwatch.com

CPAP Devices Market Overview 2023 to 2029, Future Trends and Industry Forecast | ResMed, Philips Respironics, Fisher & Paykel Healthcare

March 6, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

February 6, 2023 | finance.yahoo.com

Fisher & Paykel Healthcare (NZSE:FPH) jumps 4.7% this week, though earnings growth is still tracking behind five-year shareholder returns

January 15, 2023 | finance.yahoo.com

Is Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Recent Stock Performance Tethered To Its Strong Fundamentals?

December 1, 2022 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and IVERIC bio (ISEE)

November 30, 2022 | finance.yahoo.com

Fisher & Paykel Healthcare First Half 2023 Earnings: Beats Expectations

November 28, 2022 | seekingalpha.com

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2023 Earnings Call Transcript

October 9, 2022 | finance.yahoo.com

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

See More Headlines

Receive FSPKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Current Symbol: OTCMKTS:FSPKF
CUSIP: N/A
CIK: N/A
Web: www.fphcare.com
Phone: (649) 574-0100
Fax: N/A
Employees: 6,391
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 92.20
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Lewis G. Gradon (Age 63)
MD, CEO & Executive Director
Comp: $1.54M
Ms. Lyndal York
Chief Financial Officer
Andy Niccol
COO & GM of Respiratory Humidification
Dr. Andrew Somervell
Vice President of Products & Technology
Hayden Brown
Head of Capital Markets & Investor Relations
Raelene Leonard
Company Secretary & General Counsel
Daniel Adolph
Senior Communications & Investor Relations Manager
Mr. Marcus Driller
Vice President of Corporate
Chris Crone
General Manager of Airvo Optiflow
Sam Frame
Marketing Manager of Airvo

Key Competitors

View All Competitors

FSPKF Stock Analysis - Frequently Asked Questions

Should I buy or sell Fisher & Paykel Healthcare stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FSPKF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares.
View FSPKF analyst ratings or view top-rated stocks.
How have FSPKF shares performed in 2024?: Fisher & Paykel Healthcare's stock was trading at $14.11 at the start of the year. Since then, FSPKF shares have increased by 10.8% and is now trading at $15.64.
View the best growth stocks for 2024 here.
Are investors shorting Fisher & Paykel Healthcare?: Fisher & Paykel Healthcare saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,786,000 shares, an increase of 10.3% from the March 15th total of 1,619,600 shares. Based on an average daily trading volume, of 1,300 shares, the days-to-cover ratio is currently 1,373.8 days.
View Fisher & Paykel Healthcare's Short Interest.

Is Fisher & Paykel Healthcare a good dividend stock?: Fisher & Paykel Healthcare (OTCMKTS:FSPKF) pays an annual dividend of $0.07 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Fisher & Paykel Healthcare?: Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FSPKF) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis